Keyword: CU Chemie Uetikon
News
24.03.2016
- French private equity fund Ardian has started talks with two buy-out firms for the sale of its majority stake in chemicals and pharmaceuticals producer Novacap. The firm is in...
News
12.05.2015
- Private equity investor Equistone Partners Europe has sold its majority shareholding in German fine chemicals and pharmaceutical ingredients manufacturer CU Chemie Uetikon for an...
News
30.01.2013
- The long-standing CEO of CU Chemie Uetikon, Heinz Sieger (65) will move to the company's Supervisory Board effective 1 February, where he will assume the chairmanship. Thomas...
Chemistry & Life Sciences
29.01.2013
- A Look into the Future - Where is the U.S. economy heading in 2013? Industry leaders predict their companies will navigate uncertainty, including changes in pharmaceutical...
News
25.09.2012
- CHEManager Europe asked experts from the pharmaceutical ingredients and custom synthesis industry to share their opinions on this topic prior to the industry global networking...
News
28.10.2011
- Barclays Private Equity (BPE) has acquired a majority shareholding in CU Chemie Uetikon, a fine chemicals company based in Lahr, Germany. With a shareholding of 90%, BPE will have...
21.06.2011
- CU Chemie Uetikon CEO Heinz Sieger spoke to CHEManager Europe Editor Brandi Schuster about what his customers are looking for when it comes to custom synthesis. Sieger is also...
News
07.05.2010
- The German advertising tagline "greed is good" is now outmoded as a basic principle of purchasing. A low purchase price does not mean that a product is actually inexpensive...
